Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

The 2012 criteria are better for diagnosing atypical lupus cases.

Hair loss can be treated with medications like minoxidil and finasteride or surgery, but treatment effectiveness varies by alopecia type and accurate diagnosis is important.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

Telogen effluvium is a common type of hair loss that can resolve on its own or become chronic, with treatment depending on early diagnosis.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Immune cells are crucial for hair growth and preventing hair loss.

Vitamin D may help reduce antibody levels in men with autoimmune thyroiditis and early-onset androgenic alopecia, but has no significant impact on thyroid function.

Ruxolitinib may help treat hair loss and symptoms in patients with chronic graft-versus-host disease.

A severe medication reaction required long treatment and led to hair loss and thyroid issues.

Oral isotretinoin may slightly improve acne but increases the risk of side effects like dry lips and skin; more research is needed to understand its full risks and benefits.

Dissolving microneedles show promise for delivering medication through the skin but face challenges like manufacturing complexity and regulatory hurdles.

The conclusion is that dermatologists can improve women's skin health but must overcome cultural and economic barriers to do so.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

COVID-19 may trigger or worsen rapid hair loss in alopecia areata.

Modern lifestyles, including poor diet, stress, and long-term use of certain medications, hinder the body's ability to heal from inflammation, leading to chronic diseases.

An 18-year-old girl improved with treatment after being diagnosed with both Systemic Lupus Erythematosus and Celiac Disease.

A woman's hair loss from graft versus host disease helps understand similar hair loss conditions.

Vitamin D3 is important for bone health and may help treat various diseases beyond bone-related conditions.

Myoblast transplantation shows promise for treating various muscle and heart conditions.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

Genetic screening is crucial for accurately diagnosing APS-1 due to its varied symptoms.

A five-month-old boy with Omenn syndrome successfully recovered after a stem cell transplant with reduced intensity conditioning.

Tofacitinib helped a woman with total-body hair loss grow her hair back.

PCOS causes infertility mainly due to hormonal imbalances, insulin resistance, and chronic inflammation.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Stopping infliximab and using strong topical steroids can regrow hair lost due to psoriasiform alopecia.

Different connective tissue disorders have unique symptoms and treatments, with varying outcomes and often require ongoing care from a specialist.

Some children may develop hair loss after having COVID-19.